DE3486450D1 - 17-Alpha-Ethynyl Steroide - Google Patents

17-Alpha-Ethynyl Steroide

Info

Publication number
DE3486450D1
DE3486450D1 DE3486450T DE3486450T DE3486450D1 DE 3486450 D1 DE3486450 D1 DE 3486450D1 DE 3486450 T DE3486450 T DE 3486450T DE 3486450 T DE3486450 T DE 3486450T DE 3486450 D1 DE3486450 D1 DE 3486450D1
Authority
DE
Germany
Prior art keywords
alpha
ethynyl
steroids
ethynyl steroids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3486450T
Other languages
English (en)
Other versions
DE3486450T2 (de
Inventor
Joseph Michael Timko
Verlan Henry Vanrheenen
Dae Yang Cha
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/568,558 external-priority patent/US4526720A/en
Priority claimed from US06/602,300 external-priority patent/US4614621A/en
Priority claimed from US06/604,091 external-priority patent/US4618456A/en
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Publication of DE3486450D1 publication Critical patent/DE3486450D1/de
Application granted granted Critical
Publication of DE3486450T2 publication Critical patent/DE3486450T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16
    • C07J7/0055—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/02—Lithium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0048—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/0025—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16
    • C07J7/003—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Steroid Compounds (AREA)
DE19843486450 1984-01-05 1984-12-17 17-Alpha-Ethynyl Steroide Expired - Fee Related DE3486450T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US06/568,558 US4526720A (en) 1984-01-05 1984-01-05 Process to prepare stabilized monolithium acetylide
US59163184A 1984-03-20 1984-03-20
US06/602,300 US4614621A (en) 1984-04-20 1984-04-20 Ethynylation of 16-methylene-17-keto steroids
US06/604,091 US4618456A (en) 1984-03-20 1984-04-26 Ethynylation of 16-methyl-17-keto steroids

Publications (2)

Publication Number Publication Date
DE3486450D1 true DE3486450D1 (de) 1997-06-12
DE3486450T2 DE3486450T2 (de) 1997-11-06

Family

ID=27504873

Family Applications (2)

Application Number Title Priority Date Filing Date
DE8484308826T Expired - Fee Related DE3484464D1 (de) 1984-01-05 1984-12-17 Stabilisiertes monolithiumacetylid und ethinylierung von steroiden.
DE19843486450 Expired - Fee Related DE3486450T2 (de) 1984-01-05 1984-12-17 17-Alpha-Ethynyl Steroide

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE8484308826T Expired - Fee Related DE3484464D1 (de) 1984-01-05 1984-12-17 Stabilisiertes monolithiumacetylid und ethinylierung von steroiden.

Country Status (4)

Country Link
EP (2) EP0402963B1 (de)
JP (1) JPH0633287B2 (de)
DE (2) DE3484464D1 (de)
HK (1) HK36196A (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2678275B1 (fr) * 1991-06-25 1995-06-23 Roussel Uclaf Nouveaux sterouides 16-methyl substitue derives de la pregna 1,4-diene 3,20-dione leur preparation, leur application a la preparation de sterouides 16-methylene et nouveaux intermediaires.
EP2794632B1 (de) * 2011-12-23 2016-03-16 Crystal Pharma S.A.U Verfahren zur alkinilierung 16-substituierter 17-ketosteroide
CN114230627B (zh) * 2021-12-31 2023-09-15 湖南新合新生物医药有限公司 一种倍他米松环氧水解物中间体的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2920184A1 (de) * 1979-05-17 1980-11-27 Schering Ag 16 alpha -alkylsteroide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
EP0104054A3 (de) * 1982-09-20 1985-10-09 The Upjohn Company 16-Methylensteroide und ihre Herstellung

Also Published As

Publication number Publication date
DE3484464D1 (de) 1991-05-23
HK36196A (en) 1996-03-08
EP0148616B1 (de) 1991-04-17
JPS60172990A (ja) 1985-09-06
EP0402963A3 (de) 1991-05-29
EP0148616A3 (en) 1986-05-07
DE3486450T2 (de) 1997-11-06
EP0402963B1 (de) 1997-05-07
EP0148616A2 (de) 1985-07-17
JPH0633287B2 (ja) 1994-05-02
EP0402963A2 (de) 1990-12-19

Similar Documents

Publication Publication Date Title
NO864960L (no) Steroide liposomer.
DE3586242T2 (de) Steroid-liposome.
NO172847C (no) Mellomprodukt
ATE37883T1 (de) Steroide.
KR850009584U (ko) 패 널
BR8506798A (pt) Dispositivos fixadores
DE3486450D1 (de) 17-Alpha-Ethynyl Steroide
DK48984D0 (da) Beslag
NO167254C (no) Plaster
ATA117685A (de) Sonnenkollektor
DK327486D0 (da) Loddekop-forbindelsesorgan
NO871930L (no) C20-c26-aminosteroider.
IT1183597B (it) Autobus
KR860006286U (ko) 화 장 로
IT8418707A0 (it) Pannello fibrocromatico
NO171113C (no) Steroider
IT1197029B (it) Antiinfiammatori non steroidei
BR6400382U (pt) Painel componivel
DK434684D0 (da) Solfangerpanel
KR860000553U (ko) 봉체 골조의 연결구
RO89471A2 (ro) Panou prefabricat termoizolator autoportant
ES279666Y (es) Marquesina
KR860003816U (ko) 미장벽돌
KR850007349U (ko) 변기
KR860004504U (ko) 변 기

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee